Literature DB >> 10609653

In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response.

A Izembart1, E Aguado, O Gauthier, D Aubert, P Moullier, N Ferry.   

Abstract

Gene transfer in regenerating dog liver using high-titer recombinant retroviral vectors carrying the E. coli beta-galactosidase gene was studied. Supernatants containing amphotropic or gibbon ape pseudotyped recombinant retroviruses were infused into a peripheral vein in beagle dogs after partial hepatectomy. The kinetics of liver regeneration were determined in the animals and daily infusions were carried out for 4 or 5 days during the regeneration period. Up to 2.8% of hepatocytes were beta-galactosidase positive at the end of the procedure. However, the number of positive cells declined rapidly and few positive hepatocytes were detected after 3 weeks. PCR demonstrated the disappearance of the provirus. Histologically, inflammatory lesions were observed in the transduced livers. Finally, we demonstrated the presence of a cytotoxic T lymphocyte immune response directed against beta-galactosidase-expressing cells, which could explain the disappearance of the transgene. This work suggests that the efficiency of in vivo gene delivery using high-titer retroviral vectors directly infused into the circulation may be hampered by a cytotoxic immune response against the infected cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609653     DOI: 10.1089/10430349950016339

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  3 in total

1.  AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response.

Authors:  Marta Bellodi-Privato; Guylène Le Meur; Dominique Aubert; Alexandra Mendes-Madera; Virginie Pichard; Fabienne Rolling; Nicolas Ferry
Journal:  J Mol Med (Berl)       Date:  2004-03-24       Impact factor: 4.599

2.  Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation.

Authors:  F Xue; T Takahara; Y Yata; M Minemura; C Y Morioka; S Takahara; E Yamato; K Dono; A Watanabe
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 3.  Translating CRISPR-Cas Therapeutics: Approaches and Challenges.

Authors:  Lavina Sierra Tay; Nathan Palmer; Rebecca Panwala; Wei Leong Chew; Prashant Mali
Journal:  CRISPR J       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.